SANDBERG RICHARD A

Director Sandberg bought 1,399 shares in 2 transactions at blended avg $10.00 on 2025-05-30, now holding 40,175 shares (up 3.6%)

Richard A. Sandberg, Director, purchased 1,399 shares across 2 separate transactions on 2025-05-30 at a blended average price of $10.00, spending $13,985.52 total. This purchase follows rapid accumulation: prior trades at PRPO on 2025-05-20, 2025-05-21 (×2), 2025-05-22, and 2025-05-27 all remain within the outcome-measurement window (outcomes not yet determinable). The stock has advanced 55.2% over 30 days and trades 6.9% below its 52-week high of $10.14. However, context is critical: Precipio is unprofitable (full-year net income was negative) with quarterly net income of -$884,000.00 against revenue of $4,929,000.00, despite 22.0% annual revenue growth. The recent cluster of five buys within ten days, combined with an unprofitable balance sheet, warrants monitoring to determine whether this accumulation reflects evolving business conditions or represents a pattern driven by other factors.

Director Richard Sandberg bought 101 PRPO shares at $9.80 on 2025-05-27, fifth consecutive buy in 7 days.

Sandberg purchased 101 shares at $9.80, bringing his holdings to 38,776 shares post-transaction. This buy is noteworthy in context: it is the fifth consecutive open-market buy at PRPO within a 7-day window (2025-05-19 through 2025-05-27), signaling repeated accumulation activity at the same ticker. His cross-ticker track record shows 6 prior buys with an average 90-day return of +19.7% and a 100.00% win rate, suggesting a pattern of favorable entry timing elsewhere. However, the five prior PRPO buys are too recent (all within the last week) to have measurable 30-day or 90-day outcomes; timing efficacy at this ticker remains unproven. Precipio is a small-cap company ($15.1M market cap) with negative net income ($-884,000.00 last quarter) and no current profitability, though revenue grew 22.0% year-over-year. The stock has risen 64.8% in the last 30 days and 31.5% in the last 90 days, currently trading at $9.96, 1.8% below its 52-week high of $10.14. The repeated buying pattern over a compressed timeframe warrants attention to whether this reflects conviction in a turnaround or response to specific corporate developments.

Director Sandberg buys 500 PRPO shares at $9.33; 5 consecutive buys in 8 days amid +66.5% 30-day rally; company unprofitable

Richard A Sandberg, a Director, purchased 500 shares at $9.33 on 2025-05-22, bringing his holdings to 38,675 shares. This transaction is the sixth purchase within an 8-day window (2025-05-19 through 2025-05-27), occurring as PRPO stock surged +66.5% over 30 days and +44.2% over 90 days, now trading at $10.04 near the $10.14 52-week high. The concentrated buying pattern during a strong rally, combined with the company's unprofitable status (latest quarterly net income of $-884,000 despite +22.0% annual revenue growth and a $15.2M market cap), raises questions about whether these purchases reflect conviction or opportunistic accumulation at accelerating valuations. Investors should note that prior PRPO trade outcomes remain unmeasurable (all occurred within the last 8 days), limiting ability to assess whether Sandberg's timing decisions at this specific ticker have historically validated future price action.

Director SANDBERG purchases 8,035 shares at $9.27 avg, expanding holdings 26.7% to 38,175 shares in unprofitable PRPO

Director Richard A Sandberg executed 2 separate purchases totaling 8,035 shares for $74,473.75 on 2025-05-21, increasing his stake by 26.7% relative to pre-transaction holdings of 30,140 shares. The blended average price of $9.27 sits near the current price of $9.75 and within the 52-week range ($4.44–$10.14), though the stock has gained +78.9% over the past 30 days following a -3.8% decline over 90 days. The company remains unprofitable (net income $-884,000.00 for the latest quarter; full-year net income was negative), though revenue grew +22.0% year-over-year and the market cap stands at $14,742,107.25. His cross-ticker track record shows 4 prior buys averaging +5.8% 30-day return and +19.7% 90-day return with a 100.00% win rate, though at PRPO specifically he has executed 5 prior trades in rapid succession (three within the past 3 days), making the timing and motivation for this concentrated purchasing activity worth examining in context of company fundamentals and recent price momentum.

Director SANDBERG bought 4,965 shares at blended avg $8.43 on 2025-05-19 to 2025-05-20, raising holdings 19.7% to 30,140 shares.

Director Richard A. Sandberg purchased 4,965 shares across 2 separate transactions totaling $41,867.91 at an average price of $8.43, a 17.5% discount to the current price of $9.90. This represents a substantial 19.7% increase in his holdings over 2 days. His cross-ticker track record shows 3 prior buys with an average 90-day return of +19.7% and a 100% win rate, suggesting consistent acumen in timing open-market purchases. However, Precipio remains unprofitable with negative annual net income of $884,000.00 despite 22% annual revenue growth, and the company trades at a market cap of $15.0M with recent quarterly revenue of only $4.9M, indicating an early-stage biotech or specialized firm where director-level participation carries both conviction signal and heightened execution risk.

Director Sandberg sold 12,000 shares at $6.20 while buying 15,000 at $5.80 on 2024-12-13, net +3,000 shares (+18.2%)

Richard A. Sandberg, a Director at Precipio, Inc., executed 2 separate transactions on the same day: a sale of 12,000 shares at $6.20 and a purchase of 15,000 shares at $5.80, resulting in a net increase of 3,000 shares (+18.2% vs pre-transaction holdings). The purchase price of $5.80 is below the current price of $5.82 and significantly below the 52-week high of $6.99, though the stock has declined -8.4% over the past 30 days. The company is unprofitable (net income of $-626,000.00 in the latest quarter; full-year net income was negative) despite strong revenue growth of +61.5% year-over-year and a market cap of $8.6M. The net positive increase in holdings warrants attention given the company's current profitability challenges and stock weakness, though the sale component and price concession on the buy suggest a more mixed directional signal than a pure accumulation play.